Harmony Biosciences Holdings Inc (HRMY)
34.07
+0.84
(+2.53%)
USD |
NASDAQ |
Nov 22, 16:00
34.07
0.00 (0.00%)
Pre-Market: 20:00
Harmony Biosciences Holdings Price: 34.07 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 33.17 | 34.17 | 32.90 | 34.07 | 517890.0 |
| Nov 21, 2024 | 32.85 | 33.31 | 32.33 | 33.23 | 200979.0 |
| Nov 20, 2024 | 32.45 | 33.66 | 32.40 | 32.79 | 311029.0 |
| Nov 19, 2024 | 33.00 | 33.22 | 32.35 | 32.48 | 549418.0 |
| Nov 18, 2024 | 33.12 | 33.31 | 32.78 | 33.07 | 405837.0 |
| Nov 15, 2024 | 33.00 | 33.51 | 32.55 | 33.22 | 598332.0 |
| Nov 14, 2024 | 34.21 | 34.27 | 32.90 | 33.00 | 491147.0 |
| Nov 13, 2024 | 35.49 | 35.53 | 33.79 | 33.84 | 538184.0 |
| Nov 12, 2024 | 35.93 | 36.46 | 34.71 | 35.08 | 909051.0 |
| Nov 11, 2024 | 36.43 | 36.68 | 35.72 | 35.91 | 533681.0 |
| Nov 08, 2024 | 35.10 | 36.08 | 34.88 | 36.08 | 845073.0 |
| Nov 07, 2024 | 34.52 | 35.37 | 34.28 | 34.91 | 433368.0 |
| Nov 06, 2024 | 34.13 | 34.84 | 33.64 | 34.29 | 812457.0 |
| Nov 05, 2024 | 32.45 | 33.58 | 32.37 | 33.41 | 615773.0 |
| Nov 04, 2024 | 33.47 | 34.50 | 32.78 | 33.05 | 1.272M |
| Nov 01, 2024 | 32.50 | 34.11 | 31.48 | 33.08 | 5.616M |
| Oct 31, 2024 | 31.26 | 33.64 | 31.02 | 32.13 | 4.995M |
| Oct 30, 2024 | 37.49 | 38.00 | 33.50 | 33.80 | 2.888M |
| Oct 29, 2024 | 37.58 | 41.61 | 36.23 | 41.49 | 1.317M |
| Oct 28, 2024 | 34.83 | 35.80 | 34.63 | 35.75 | 809748.0 |
| Oct 25, 2024 | 34.10 | 34.90 | 33.91 | 34.50 | 450754.0 |
| Oct 24, 2024 | 34.00 | 34.50 | 33.80 | 34.05 | 394385.0 |
| Oct 23, 2024 | 34.80 | 34.98 | 33.84 | 34.05 | 381801.0 |
| Oct 22, 2024 | 34.61 | 35.29 | 34.61 | 34.86 | 392595.0 |
| Oct 21, 2024 | 35.37 | 35.44 | 34.63 | 34.95 | 731796.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
19.20
Minimum
Oct 27 2023
60.91
Maximum
Dec 05 2022
37.79
Average
35.86
Median
Dec 28 2020
Price Benchmarks
| Regeneron Pharmaceuticals Inc | 738.00 |
| Incyte Corp | 71.72 |
| EyePoint Pharmaceuticals Inc | 8.95 |
| Cassava Sciences Inc | 26.48 |
| Capricor Therapeutics Inc | 18.62 |
Price Related Metrics
| PE Ratio | 16.15 |
| PS Ratio | 2.899 |
| Price to Book Value | 3.256 |
| Price to Free Cash Flow | 8.977 |
| Earnings Yield | 6.19% |
| Market Cap | 1.943B |
| Operating PE Ratio | 11.28 |
| Normalized PE Ratio | 16.15 |